These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1862442)

  • 1. Reversal of structural changes in hypertensive--a major prospect for the future?
    Rosendorff C
    S Afr Med J; 1991 Aug; 80(3):121-2. PubMed ID: 1862442
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of structural changes in hypertensive arteries--a major prospect for the future.
    Rosendorff C
    S Afr Med J; 1991 Sep; Suppl():4-6. PubMed ID: 1925814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme (ACE) inhibitors in experimental hypertension: influence on heart and arteries.
    Levy BI; Salzmann JL; Devissaguet M; Safar ME; Michel JB
    Basic Res Cardiol; 1991; 86 Suppl 1():43-53. PubMed ID: 1827984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive therapy with angiotensin converting enzyme inhibitors or calcium antagonists on spontaneous cyclic vasomotor activity in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D; Porteri E; Castellano M; Bettoni G; Muiesan ML; Salvetti M; Cinelli A; Agabiti-Rosei E
    J Hypertens; 1995 Dec; 13(12 Pt 2):1827-32. PubMed ID: 8903661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of perindopril on structural and functional changes in hypertensive arteries.
    Thomas JR; Asmar RG; Safar ME
    S Afr Med J; 1991 Oct; Suppl():6-9. PubMed ID: 1925815
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin converting enzyme: its molecular function, new ACE inhibitors and future prospect].
    Shionoiri H; Sugimoto K; Takasaki I; Yasuda G
    Nihon Rinsho; 1992 Apr; 50 Suppl():743-52. PubMed ID: 1321923
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of angiotensin-converting enzyme inhibitors in preventing or reducing end-organ damage in hypertension.
    Doyle AE
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S21-7. PubMed ID: 1381791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular protection with cilazapril in hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S28-33. PubMed ID: 1381792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension.
    Asmar RG; Iannascoli F; Benetos A; Safar ME
    J Hypertens Suppl; 1992 Jul; 10(5):S13-9. PubMed ID: 1403229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function and structure of the vascular wall in experimental arterial hypertension. Effect of treatment].
    Michel JB; Tedgui A; Salzmann JL; Belmain J; Lévy B
    Nephrologie; 1989; 10(2):55-7. PubMed ID: 2677815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
    Coats AJ
    Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Converting enzyme inhibitors in the treatment of arterial hypertension].
    Guedon J; Guedon-Moreau L
    Ann Cardiol Angeiol (Paris); 1988 Dec; 37(10):559-62. PubMed ID: 3223720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience.
    Materson BJ; Preston RA
    Arch Intern Med; 1994 Mar; 154(5):513-23. PubMed ID: 8122944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.